#GS3 #Science&Technology 

Indian doctors have said the reported success of dexamethasone — an inexpensive steroid that retails for less than ₹10 for 10 ml and is made by several Indian manufacturers — in saving the lives of COVID-19 patients on ventilators is good news for the country. 


  • Scientists administering the WHO-administered RECOVERY trial, the largest global clinical trial that is checking the ability of several repurposed drugs to treat COVID-19, reported that dexamethasone reduced deaths by one-third in ventilated patients and by one-fifth in other patients receiving oxygen only.  
  • There was no benefit among those patients who did not require respiratory support. 

What is ‘Dexamethasone’? 

  • Dexamethasone is a steroid (not an antiviral drug) – a medicine that reduces inflammation by mimicking anti-inflammatory hormones produced by the body. 
  • This drug works by dampening down the body’s immune system. 
  • Coronavirus infection triggers inflammation as the body tries to fight it off. But sometimes the immune system goes into overdrive and it’s this reaction that can prove fatal – the very reaction designed to attack infection ends up attacking the body’s own cells. 
  • Dexamethasone calms this effect. It’s only suitable for people who are already in hospital and receiving oxygen or mechanical ventilation – the most unwell. 
  • The drug does not work on people with milder symptoms, and suppressing their immune system at this point would not be helpful. 
Print Friendly and PDF
blog comments powered by Disqus